Likewise, the identification of three AQP5 mediating miRNAs (miR-19a-3p, miR-1226–3p, and miR-19b-3p) which reduce breast cancer cell motility by lowering AQP5 translation supports the concept of additional research to prove it as potential therapeutic target [167]. This evidence concerns the gene AQP5 and breast carcinoma.